Cargando…
Trial participation as avoidance strategy: a qualitative study
BACKGROUND: Trial participation decisions are often influenced by expectations of potential benefit. Attention has focused on trial participation as a means of securing something seen as desirable, such as experimental treatment. In contrast, we consider a case in which one trial arm involved receiv...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139059/ https://www.ncbi.nlm.nih.gov/pubmed/26730890 http://dx.doi.org/10.1111/hex.12437 |
_version_ | 1782472175954952192 |
---|---|
author | Armstrong, Natalie Shaw, Elizabeth McColl, Elaine Tincello, Douglas G. Hilton, Paul |
author_facet | Armstrong, Natalie Shaw, Elizabeth McColl, Elaine Tincello, Douglas G. Hilton, Paul |
author_sort | Armstrong, Natalie |
collection | PubMed |
description | BACKGROUND: Trial participation decisions are often influenced by expectations of potential benefit. Attention has focused on trial participation as a means of securing something seen as desirable, such as experimental treatment. In contrast, we consider a case in which one trial arm involved receiving less than usual care. We explore how this influenced participants’ decisions to participate. METHODS: Semi‐structured interviews with 29 women participating in a pilot trial comparing invasive urodynamic testing (typically normal care) to basic clinical assessment with non‐invasive tests, prior to surgical treatment for stress urinary incontinence. Analysis was based on the constant comparative method. RESULTS: Invasive tests were something many were aware of and worried about. Participants understood that trial participation meant they might avoid having these tests, and for about one‐third, this was the primary factor motivating participation. A further third mentioned they were not looking forward to tests (if allocated to them) or were lucky to have missed them (if allocated to basic clinical assessment). None of the women appeared to have discussed their desire to avoid having invasive tests with their clinicians. CONCLUSIONS: In contrast to cases in which trial participation is motivated by the wish to secure an intervention not otherwise available, this study reports the opposite – trial participation as an opportunity to avoid having something regarded as undesirable. The option to decline a particular intervention should always be available, and care must be taken to ensure that potential participants are aware that trial participation is not the only possible means of avoidance. |
format | Online Article Text |
id | pubmed-5139059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-51390592016-12-12 Trial participation as avoidance strategy: a qualitative study Armstrong, Natalie Shaw, Elizabeth McColl, Elaine Tincello, Douglas G. Hilton, Paul Health Expect Original Research Papers BACKGROUND: Trial participation decisions are often influenced by expectations of potential benefit. Attention has focused on trial participation as a means of securing something seen as desirable, such as experimental treatment. In contrast, we consider a case in which one trial arm involved receiving less than usual care. We explore how this influenced participants’ decisions to participate. METHODS: Semi‐structured interviews with 29 women participating in a pilot trial comparing invasive urodynamic testing (typically normal care) to basic clinical assessment with non‐invasive tests, prior to surgical treatment for stress urinary incontinence. Analysis was based on the constant comparative method. RESULTS: Invasive tests were something many were aware of and worried about. Participants understood that trial participation meant they might avoid having these tests, and for about one‐third, this was the primary factor motivating participation. A further third mentioned they were not looking forward to tests (if allocated to them) or were lucky to have missed them (if allocated to basic clinical assessment). None of the women appeared to have discussed their desire to avoid having invasive tests with their clinicians. CONCLUSIONS: In contrast to cases in which trial participation is motivated by the wish to secure an intervention not otherwise available, this study reports the opposite – trial participation as an opportunity to avoid having something regarded as undesirable. The option to decline a particular intervention should always be available, and care must be taken to ensure that potential participants are aware that trial participation is not the only possible means of avoidance. John Wiley and Sons Inc. 2016-01-05 2016-12 /pmc/articles/PMC5139059/ /pubmed/26730890 http://dx.doi.org/10.1111/hex.12437 Text en © 2016 The Authors Health Expectations Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Papers Armstrong, Natalie Shaw, Elizabeth McColl, Elaine Tincello, Douglas G. Hilton, Paul Trial participation as avoidance strategy: a qualitative study |
title | Trial participation as avoidance strategy: a qualitative study |
title_full | Trial participation as avoidance strategy: a qualitative study |
title_fullStr | Trial participation as avoidance strategy: a qualitative study |
title_full_unstemmed | Trial participation as avoidance strategy: a qualitative study |
title_short | Trial participation as avoidance strategy: a qualitative study |
title_sort | trial participation as avoidance strategy: a qualitative study |
topic | Original Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139059/ https://www.ncbi.nlm.nih.gov/pubmed/26730890 http://dx.doi.org/10.1111/hex.12437 |
work_keys_str_mv | AT armstrongnatalie trialparticipationasavoidancestrategyaqualitativestudy AT shawelizabeth trialparticipationasavoidancestrategyaqualitativestudy AT mccollelaine trialparticipationasavoidancestrategyaqualitativestudy AT tincellodouglasg trialparticipationasavoidancestrategyaqualitativestudy AT hiltonpaul trialparticipationasavoidancestrategyaqualitativestudy |